Sign in

CIK 0001341235

  • Non-accelerated filer
  • Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
Open-market buys, last 90 days
$140,275
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-08-11 Machatha Stephen Chief Development Officer Sale −22,073 $5.15 $114K 221,799
2025-03-04 Machatha Stephen Chief Development Officer Grant or award · Stock Option (right to buy) +202,427 202,427
2024-08-12 Machatha Stephen Chief Development Officer Sale −16,041 $4.74 $76K 236,771
2024-03-12 Machatha Stephen Chief Development Officer Sale −11,537 $3.16 $37K 252,812
2024-03-12 Machatha Stephen Chief Development Officer Sale −11,537 $3.16 $37K 243,495
2024-03-11 Machatha Stephen Chief Development Officer Sale −18,231 $3.41 $62K 255,032
2024-03-09 Machatha Stephen Chief Development Officer Grant or award · Stock Option (right to buy) +405,450 405,450
2023-02-28 Machatha Stephen Chief Development Officer Grant or award · Stock Option (right to buy) +220,258 220,258
2022-07-15 Machatha Stephen Chief Development Officer Grant or award +185,605 273,263
2022-07-15 Machatha Stephen Chief Development Officer Grant or award · Bonus Units +69,473 69,473
2022-03-30 Machatha Stephen Chief Development Officer Grant or award +64,395 87,658
2022-03-30 Machatha Stephen Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +250,000 250,000
2021-04-12 Machatha Stephen Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +116,201 116,201

Page 1 of 1 · 13 trades